| Literature DB >> 35208520 |
Anna Maria Cybulska1, Kamila Rachubińska1, Małgorzata Starczewska1, Labib Zair2, Mariusz Panczyk3.
Abstract
Background andEntities:
Keywords: COVID-19; SARS-CoV-2; anxiety; depression; health; insomnia; stress
Mesh:
Year: 2022 PMID: 35208520 PMCID: PMC8876927 DOI: 10.3390/medicina58020196
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Flowchart of survey participation.
Sociodemographic variables.
| Variables ( |
| % | |
|---|---|---|---|
| Gender | Female | 256 | 79.3 |
| Male |
| 20.7 | |
| Marital status | Formal relationship | 153 | 47.4 |
| Informal relationship | 78 | 24.1 | |
| Single/divorced/widowed | 92 | 28.5 | |
| Education | Secondary | 57 | 17.6 |
| post-secondary | 14 | 4.3 | |
| Higher (I) | 99 | 30.7 | |
| Higher (II) | 141 | 43.7 | |
| Higher (III) | 12 | 3.7 | |
| Place of residence | village | 67 | 20.7 |
| city with up to 10,000 people | 16 | 5.0 | |
| city with 10,000–100,000 people | 56 | 17.3 | |
| city with over 100,000 people | 184 | 57.0 | |
| Children | No | 160 | 49.5 |
| Yes | 155 | 48.0 | |
| Pregnancy | 8 | 2.5 | |
N, whole cohort size; n, number of; %, percent.
The psychosocial functioning (anxiety, depression, insomnia, stress) of the respondents.
| Severity Category (Points) | ||||||
|---|---|---|---|---|---|---|
| Variables | M | SD | Me | IQR/2 | Min-Max | CV [%] |
| AIS | 7.56 | 4.51 | 7.0 | 3.5 | 0.0–24.0 | 59.6 |
| GAD-7 | 15.34 | 5.95 | 14.0 | 4.5 | 7–28 | 38.8 |
| PHQ-9 | 18.30 | 6.35 | 18.0 | 4.5 | 9–36 | 34.7 |
| PSS-10 | 7.30 | 1.60 | 8.0 | 0.5 | 0.0–10.0 | 21.9 |
M—mean; SD—standard deviation; Me—median; IQR/2—interquartile range; Min—minimum; Max—maximum; CV—coefficient of variation; GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale.
The psychosocial functioning (anxiety, depression, insomnia, stress) of the respondents.
| Severity Category | |||
|---|---|---|---|
| Variables (Points) |
| % | |
| AIS | no insomnia disorder | 171 | 52.9 |
| yes >8 points | 152 | 47.1 | |
| GAD-7 | no anxiety disorder (0–4 points) | 95 | 29.41 |
| mild anxiety disorder (5–9 points) | 110 | 34.06 | |
| moderate anxiety disorder (10–14 points) | 61 | 18.89 | |
| severe anxiety disorder (15–21 points) | 57 | 17.65 | |
| PHQ-9 | no depression (0–4 points) | 84 | 26.01 |
| mild depression (5–9 points) | 93 | 28.79 | |
| moderate depression (10–14 points) | 76 | 23.53 | |
| moderately severe depression (15–19 points) | 47 | 14.55 | |
| severe depression (20–27 points) | 23 | 7.12 | |
| PSS-10 | low stress (1–4 sten) | 18 | 5.6 |
| medium stress (5–6 sten) | 62 | 19.2 | |
| high stress (7–10 sten) | 243 | 75.2 | |
GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale; n-number of, %-percent.
Correlations between the respondents’ age and their psychosocial functioning (anxiety, depression, insomnia, stress).
| Psychosocial Functioning Parameters | Pearson’s r | t |
|
|---|---|---|---|
| AIS | −0.11 | −1.99 | 0.048 |
| GAD-7 | −0.06 | −1.061 | 0.289 |
| PHQ-9 | −0.16 | −2.907 | 0.004 |
| PSS-10 | 0.01 | 0.155 | 0.877 |
GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale; t-Student’s t-distribution, p—significance level.
The psychosocial functioning (anxiety, depression, insomnia, and stress) of the respondents depending on their sex.
| Variables | Women | Men | t |
| ||
|---|---|---|---|---|---|---|
| M | SD | M | SD | |||
| AIS | 7.66 | 4.51 | 7.18 | 4.52 | 0.777 | 0.438 |
| GAD-7 | 15.78 | 6.04 | 13.66 | 5.34 | 2.623 | 0.009 |
| PHQ-9 | 18.71 | 6.38 | 16.75 | 6.00 | 2.270 | 0.024 |
| PSS-10 | 7.40 | 1.49 | 6.90 | 1.92 | 2.328 | 0.021 |
M—mean; SD—standard deviation; t—Student’s t-distribution, p—significance level; GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale.
The psychosocial functioning (anxiety, depression, insomnia, stress) of the respondents depending on their parental status.
| Variables | Children | F | ||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Pregnancy | ||||||
| M | SD | M | SD | M | SD | |||
| AIS | 6.94 | 4.19 | 8.16 | 4.69 | 7.63 | 5.63 | 2.955 | 0.054 |
| GAD-7 | 14.67 | 5.81 | 16.07 | 6.08 | 13.75 | 4.74 | 2.484 | 0.085 |
| PHQ-9 | 17.14 | 5.98 | 19.53 | 6.54 | 16.25 | 5.09 | 6.201 | 0.002 |
| PSS-10 | 7.30 | 1.68 | 7.31 | 1.52 | 7.00 | 1.51 | 0.141 | 0.868 |
M—mean; SD—standard deviation; F—the value of the test statistic; p—significance level; * one way ANOVA; GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale.
Correlations between the parameters of psychosocial functioning.
| Variables | Pearson’s r | t |
| |
|---|---|---|---|---|
| GAD-7 | AIS | 0.53 | 11.24 | <0.001 |
| PSS-10 | 0.50 | 10.236 | <0.001 | |
| PHQ-9 | GAD-7 | 0.76 | 21.14 | <0.001 |
| AIS | 0.65 | 15.35 | <0.001 | |
| PSS-10 | 0.45 | 8.919 | <0.001 | |
| PSS-10 | AIS | 0.32 | 6.129 | <0.001 |
GAD-7—Generalized Anxiety Disorder-7; PHQ-9—Patient Health Questionnaire-9; AIS—Athens Insomnia Scale; PSS-10—Perceived Stress Scale; p—significance level.